Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report

被引：0
|
作者：
Centrone, Renato [1 ]
Bellesso, Marcelo [1 ]
Bonito, Debora [2 ]
Dias, Daniela [1 ]
Santucci, Rodrigo [1 ]
Aranha, Milton [1 ]
Alves, Adelson [1 ]
机构：
[1] Inst Hemomed Oncol & Hematol, Av Arnolfo Azevedo 108, BR-01236030 Sao Paulo, SP, Brazil
[2] Fac Med ABC, Sao Paulo, SP, Brazil
来源：
HEMATOLOGY TRANSFUSION AND CELL THERAPY | 2020年 / 42卷 / 04期
关键词：
DIAGNOSED CHRONIC-PHASE; FOLLOW-UP; THERAPY;
D O I：
10.1016/j.htct.2019.09.003
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：373 / 375
页数：3
相关论文
共 50 条
  • [31] COST Effectiveness of FRONT Nilotinib or Dasatinib VS IMATINIB AS FIRST LINE TREATMENT of CHRONIC Myeloid LEUKEMIA In Colombia
    Emilio Romero, Martin, Sr.
    Alvis, Nelson, Sr.
    de Acevedo, Magali, Sr.
    Rocio Chavez, Diana, Sr.
    BLOOD, 2011, 118 (21) : 1794 - 1794
  • [32] Nilotinib-Induced Elephantine Psoriasis In a Patient With Chronic Myeloid Leukemia: A Rare Case Report and Literature Review
    Sadatmadani, Seyedeh Fatemeh
    Malakoutikhah, Zahra
    Mohaghegh, Fatemeh
    Peikar, Mohammadsaleh
    Saboktakin, Mahdi
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2022, 96
  • [33] Lichen planopilaris-like eruption in chronic myeloid leukemia patient during treatment with nilotinib as second-line therapy
    Gardellini, Angelo
    Guidotti, Francesca
    Zancanella, Michelle
    Maino, Elena
    Steffanoni, Sara
    Turrini, Mauro
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2022, 28 (04) : 969 - 971
  • [34] Imatinib-induced hyperpigmentation of the hard palate in a Japanese patient with chronic myeloid leukemia: A case report
    Kono, Tatsuyuki
    Abe, Ayaka
    Uchida, Kana
    Takahashi, Yoshihiro
    Kawano, Kenji
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY MEDICINE AND PATHOLOGY, 2022, 34 (06) : 842 - 844
  • [35] Nilotinib As Second or Third-Line Therapy for Myeloid Chronic Leukemia Chronic-Phase in Mexican Patients
    Ayala, Manuel
    Dominguez, Jacqueline
    Chavez, Antonieta
    BLOOD, 2016, 128 (22)
  • [36] Second-Line Therapy for Patients With Chronic Myeloid Leukemia Resistant to First-Line Imatinib
    Lau, Anna
    Seiter, Karen
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (03): : 186 - 196
  • [37] Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China
    Li, Na
    Zheng, Bin
    Cai, Hong-Fu
    Yang, Jing
    Luo, Xiao-Feng
    Weng, Li-Zhu
    Zhan, Feng-Mei
    Liu, Mao-Bai
    CLINICAL DRUG INVESTIGATION, 2018, 38 (01) : 79 - 86
  • [38] Cost Effectiveness of Imatinib, Dasatinib, and Nilotinib as First-Line Treatment for Chronic-Phase Chronic Myeloid Leukemia in China
    Na Li
    Bin Zheng
    Hong-Fu Cai
    Jing Yang
    Xiao-Feng Luo
    Li-Zhu Weng
    Feng-Mei Zhan
    Mao-Bai Liu
    Clinical Drug Investigation, 2018, 38 : 79 - 86
  • [39] Similar Efficacy of Dasatinib and Nilotinib As Second-Line Therapy in Patients with Chronic Phase Chronic Myeloid Leukemia Failing Imatinib: A Retrospective, Real-Life Study
    Tiribelli, Mario
    Bonifacio, Massimiliano
    Binotto, Gianni
    Iurlo, Alessandra
    Cibien, Francesca
    Maino, Elena
    Guella, Anna
    Festini, Gianluca
    Minotto, Claudia
    De Biasi, Ercole
    De Marchi, Federico
    Scaffidi, Luigi
    Frison, Luca
    Bucelli, Cristina
    Medeot, Marta
    Calistri, Elisabetta
    Krampera, Mauro
    Gherlinzoni, Filippo
    Semenzato, Gianpietro
    Ambrosetti, Achille
    Pizzolo, Giovanni
    Fanin, Renato
    BLOOD, 2016, 128 (22)
  • [40] Hyperthyroidism by Nilotinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia: A case report
    Alvarez-Payero, M.
    Loureiro-Santamaria, C.
    Martin-Vila, A.
    Martinez-Lopez de Castro, N.
    Suarez-Santamaria, M.
    Pineiro-Corrales, G.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (06) : 1310 - 1310
12345